These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. [Evaluation of the Doppler-pulse volume recorder in Raynaud's phenomenon]. Sciannameo F; Tazza D; Alberti D; Marianeschi P; Cao PG; Francucci M Arch Sci Med (Torino); 1983; 140(4):353-6. PubMed ID: 6673699 [TBL] [Abstract][Full Text] [Related]
49. Haemorrheological effects of prostaglandin E1 infusion in Raynaud's syndrome. Lucas GS; Simms MH; Caldwell NM; Alexander SJ; Stuart J J Clin Pathol; 1984 Aug; 37(8):870-3. PubMed ID: 6540787 [TBL] [Abstract][Full Text] [Related]
50. Plasmapheresis in Raynaud's phenomenon in systemic sclerosis: a microcirculatory study. Jacobs MJ; Jörning PJ; Van Rhede van der Kloot EJ; Kitslaar PJ; Lemmens HA; Slaaf DW; Reneman RS Int J Microcirc Clin Exp; 1991 Feb; 10(1):1-11. PubMed ID: 2019479 [TBL] [Abstract][Full Text] [Related]
51. [Ultrasonic dopplerography and photoplethysmography in the diagnosis of Raynaud's syndrome]. Druzhinin SO Revmatologiia (Mosk); 1989; (4):54-7. PubMed ID: 2700238 [TBL] [Abstract][Full Text] [Related]
52. Plethysmographic cold test for diagnosis and evaluation of the severity of Raynaud's phenomenon. Validation of the method by factorial analysis of correspondences in 541 patients. Pistorius MA; Planchon B; de Faucal P Int Angiol; 1994 Mar; 13(1):10-4. PubMed ID: 8077791 [TBL] [Abstract][Full Text] [Related]
53. Comparison of the hunting reaction in normals and individuals with Raynaud's disease. Jobe JB; Goldman RF; Beetham WP Aviat Space Environ Med; 1985 Jun; 56(6):568-71. PubMed ID: 4015569 [TBL] [Abstract][Full Text] [Related]
54. [Hyperviscosity and Raynaud's symptoms in IgG3-kappa-plasmacytoma]. Fliege R; Ehret W; Fateh-Moghadam A; Blumenstein M; Lamerz R Internist (Berl); 1983 Oct; 24(10):587-90. PubMed ID: 6358110 [No Abstract] [Full Text] [Related]
55. Linear and nonlinear analysis of blood flow in healthy subjects and in subjects with Raynaud's phenomenon. Stefanovska A; Leger P; Bracic M; Bracic T; Bendayan P; Boccalon H Technol Health Care; 1999; 7(2-3):225-41. PubMed ID: 10463311 [TBL] [Abstract][Full Text] [Related]
56. [Various plasma components and whole blood viscosity in patients with the vascular form of vibration disease]. Turczyński B; Sroczyński J; Wegiel A Med Pr; 1985; 36(5):303-8. PubMed ID: 3831700 [TBL] [Abstract][Full Text] [Related]
57. Alpha-adrenergic receptors in platelets from patients with Raynaud's syndrome. Keenan EJ; Porter JM Surgery; 1983 Aug; 94(2):204-9. PubMed ID: 6308842 [TBL] [Abstract][Full Text] [Related]
58. Local cold exposure test with a new arterial photoplethysmographic sensor in healthy controls and patients with secondary Raynaud's phenomenon. Hahn M; Hahn C; Jünger M; Steins A; Zuder D; Klyscz T; Büchtemann A; Rassner G; Blazek V Microvasc Res; 1999 Mar; 57(2):187-98. PubMed ID: 10049666 [TBL] [Abstract][Full Text] [Related]
59. Assessment of pinacidil in patients with primary Raynaud's phenomenon. Dompeling EC; Smit AJ Vasa Suppl; 1992; 34():34-7. PubMed ID: 1529416 [TBL] [Abstract][Full Text] [Related]
60. Immune complexes in peripheral blood polymorphonuclear leucocytes of patients with Raynaud's phenomenon. van der Maulen J; Wouda AA; Mandema E; The TH Clin Exp Immunol; 1979 Jan; 35(1):62-6. PubMed ID: 428147 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]